Medicines-led PCN efficiency

18th December 2025

Medicines-led PCN efficiency is often discussed in the context of digital tools, hub models and workforce expansion. These all matter. But in practice, many PCNs find that workload pressure remains stubbornly high, even after new systems and pharmacy roles are introduced.

The reason is simple.

Efficiency in primary care is usually decided by how medicines workflows are designed.

Medicines touch almost every patient, every week. When prescribing, monitoring and review processes are fragmented or poorly owned, inefficiency becomes embedded across the system. When medicines workflows are deliberately designed, capacity is released across the entire network.

This article explains what Medicines-led PCN efficiency really means, why it matters, and how PCNs can approach it as a system rather than a series of disconnected tasks.

Key takeaways

• PCN efficiency is driven more by Medicines workflow design than tools or staffing alone
• Fragmented prescribing processes increase workload, variation and clinical risk
• Medicines-led workflow design releases capacity across practices, not just pharmacy teams
• Structured Medication Reviews deliver value only when embedded into end-to-end workflows
• Governance is what turns short-term efficiency gains into long-term value

What PCN efficiency Really Means in Practice

PCN efficiency is often discussed in terms of access, appointments and demand management. For PCN leaders, efficiency is usually felt in three practical ways.

Operational efficiency means fewer hand-offs, fewer interruptions and fewer avoidable queries. Clinical efficiency shows up as safer prescribing, better monitoring and fewer escalations. Workforce efficiency means the right work is being done by the right role, first time.

When any one of these breaks down, pressure appears elsewhere, usually as GP interruption, admin overload or increased clinical risk.

Medicines workflows sit across all three.

When Medicines workflows in primary care are poorly designed, inefficiency shows up simultaneously as operational drag, clinical risk and misaligned workforce effort.

Why Medicines Sit at the Centre of PCN Workload

Unlike appointments, medicines create continuous demand.

Every PCN and Practice manages repeat prescriptions, acute prescribing, monitoring and recalls, medication queries, hospital discharge changes, Structured Medication Reviews (SMRs) and safety alerts. This work arrives constantly, across multiple practices and multiple roles. This is because medicines workflows in primary care are continuous by nature, creating demand that cuts across clinical, administrative and pharmacy teams every day.

In many PCNs, Medicines workflows in primary care account for a significant proportion of daily GP and managerial interruptions. Repeat prescribing at PCN level and medicines-related queries generate thousands of contacts each month, often cutting across clinical, administrative and pharmacy teams.

That is why medicines are one of the most underestimated drivers of workload, variation and risk.

Medicines related work-streams never switch off in primary care. Until PCNs design medicines workflows properly, efficiency initiatives will always feel temporary.

Adeem Azhar, Co-Founder and Chief Executive Officer – Core Prescribing Solutions

If medicines workflows are fragmented, inefficiency multiplies. When they are designed properly, pressure reduces everywhere else.

FAQs

Where PCN efficiency Commonly Breaks Down

Many PCNs invest in efficiency initiatives but continue to experience the same pressures. The causes are usually consistent.

Medicines tasks are split between practices, roles and systems, with no clear end-to-end ownership. Variation between practices creates duplication and confusion at PCN level. Repeat prescribing is treated as admin rather than a safety-critical workflow requiring structure and governance. At scale, repeat prescribing at PCN level becomes one of the most significant sources of avoidable interruption when processes are inconsistent or poorly owned.

Structured Medication Reviews are often bolted on rather than embedded, delivered as isolated activity without redesigning what happens before and after the review. Clinical Pharmacy teams absorb work without the authority or escalation routes needed to resolve issues fully.

In these situations, the workload is simply moved, not removed.

What Medicines workflow design Actually Means

Medicines-led PCN efficiency starts with workflow design, not activity volume.

In practice, this is where medicines optimisation in PCNs shifts from a clinical concept into an operational discipline.

Medicines workflow design means deliberately defining how prescribing, monitoring and review work flows across the network from start to finish. This includes clear end-to-end ownership, standardised protocols across practices, defined escalation thresholds and decision-making authority.

It also means embedding SMRs into routine prescribing processes, using electronic Repeat Dispensing (eRD) as the default where clinically appropriate, and putting governance, reporting and review mechanisms around the entire workflow.

This shifts medicines from a background burden into managed infrastructure.

The Building Blocks of Medicines-led PCN efficiency

Medicines-led efficiency is not one initiative. It is an integrated system made up of several components.

Medicines optimisation in PCNs provides the clinical framework for safer, more effective prescribing when delivered consistently across practices. When delivered consistently across practices, it reduces variation, improves monitoring and supports better decision-making. This is why many PCNs invest in structured approaches to medicines optimisation and medication safety rather than isolated interventions.

Repeat prescribing at PCN level is one of the highest-volume workflows in primary care. Treating it as infrastructure rather than admin reduces interruption, improves safety and releases capacity across practices.

Prescribing hubs allow PCNs to standardise medicines workflows, improve oversight and reduce duplication. When clinically governed, Prescribing hubs that standardise medicines workflows can significantly reduce medicines-related GP workload and variation.

Clinical Pharmacists and Pharmacy Technicians play a critical role when they are embedded into workflows with clear scope, authority and escalation routes. When Clinical pharmacists in PCNs are given defined ownership of medicines workflows, supported by clear protocols and escalation routes, efficiency gains are sustained rather than short-lived. Clinical pharmacist support within PCNs is most effective when aligned to operating models rather than used to plug gaps.

Structured Medication Reviews deliver the most value when they are targeted and integrated into wider prescribing processes. This approach aligns with NHS guidance on Structured Medication Reviews, which prioritises outcomes and clinical impact over activity volume.

Governance Is the Difference Between Efficiency and Risk

Efficiency without governance is short-lived.

Sustainable medicines optimisation in PCNs depends on clear governance, shared protocols and routine review of prescribing data.

High-performing PCNs have clear Prescribing governance in primary care, agreed PCN-wide protocols, defined clinical oversight and regular review of prescribing data and exceptions. This reflects NICE guidance on medicines optimisation, which emphasises safety, consistency and value alongside efficiency.

Without governance, efficiency gains often reverse as risk and rework increase.

What High-Performing PCNs Do Differently

PCNs that consistently reduce workload and variation treat medicines as core operational infrastructure. They design workflows once and deliver them at scale, reduce interruption upstream rather than downstream, measure avoided work rather than completed tasks, align pharmacy roles to workflows and review medicines processes as part of routine governance.

Efficiency becomes a system property rather than a series of fixes.

Summary and next steps

PCN efficiency is not just about access models, digital tools or workforce numbers. It is shaped every day by how medicines work is designed and delivered.

When medicines workflows are fragmented, inefficiency spreads across the system. When they are designed deliberately, PCNs unlock capacity, reduce risk and create more resilient primary care.

Is your PCN’s medicines workflow acting as a drain or a driver of workload? A medicines workflow diagnostic can quickly identify where interruption, variation and risk are being created across your network.

This is the foundation of Medicines-led PCN efficiency.